- Home
- Equipment
- netherlands
- human papillomavirus hpv
Refine by
Human Papillomavirus Hpv Equipment Supplied In Netherlands
5 equipment items found
Manufactured by:Capricorn Life Sciences b.v. based inThe Hague, NETHERLANDS
CERVACARE spray based Carboxymethyl Betaglucan, EGCG from green tea, Resveratrol and Curcuminoids for the symptomatic treatment of Human Papilloma Virus (HPV) infection. It has a moisturising and soothing effect that creates a protective barrier in the irritated or inflamed areas of the cervical-vaginal mucosa, protecting from external microbial agents and helping to maintain and control the ...
by:CC Diagnostics based inGroningen, NETHERLANDS
CC Diagnostics collaborates with the DNA methylation ResearchGroup at the UMCG (heade by Dr G. Bea A. Wisman, molecular biologist and external scientific advisor for CC Diagnostics, and by Prof dr. Ed Schuuring, clinical scientist in molecular pathology). During their fundamental research in the last 15 years, this group has identified and clinically-validated numerous CIN2+-specific ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
The methylation assay pipeline of Self-screen has now been extended with the Precursor-M Gold assay. The newly developed Precursor-M Gold assay is currently available for Research Use Only indications. Precursor-M Gold demonstrates very good clinical performance in the detection of high grade precursor stadia and cervical cancer among HPV positive women. The assay is ready for further IVD ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
The QIAsure Methylation Test is intended to be used as a triage test for women with a positive HPV DNA test or for women with ASC-US cytology to identify those women who need to be referred for colposcopy. The QIAsure Methylation Test is a multiplex real-time methylation specific PCR-based (qMSP) assay that detects hyper methylation of 2 disease related marker genes, FAM19A4 and mir124-2, to ...
Manufactured by:ViciniVax BV based inGroningen, NETHERLANDS
Our first product candidate Vvax001, a therapeutic cancer vaccine against (pre)malignant cervical lesions, is currently in clinical development. We outsource process development and GMP manufacturing to experienced CMO’s, leading to a first clinical trial, which has been started in ...